Participant education and informed consent communication

The manuals converge on informed consent as a formal, written step that comes before participation or study-specific procedures. Across the extracts, consent is tied to voluntariness, respect for participant autonomy, and ethical oversight, with several sources also noting that procedures must align with approved protocols, ethics review, or human-subject protections. They also share an emphasis on clear disclosure, so participants understand the experimental nature of the intervention and the basic expectations of involvement. The manuals differ in how much detail they place inside the consent conversation. The psilocybin protocol gives the broadest education checklist, including study procedures, psychological and physiological risks, medication, alcohol, activity, confidentiality, unknown risks, possible emotional reactions, changes in perception, and opportunities for questions. The ibogaine manual is more explicit about medical risk, including fatalities, drug interactions, medical instability, dose, monitoring, aftercare, and likely benefits, while the ketamine and mescaline extracts focus more on written consent, privacy, dignity, and voluntariness. The ayahuasca trial adds the right to withdraw and adherence to the Declaration of Helsinki, and the ketamine study uniquely mentions a signed copy of the consent form and a limited verbal waiver for phone screening.